Remove tag real-world-evidence
article thumbnail

Pioneering the Path Pre- and Post-Launch Strategies

PM360

Driving an Integrated Evidence Strategy Evidence-based decision-making and differentiation are of paramount importance for HCPs who are flooded with therapy options or are circumspect to adopt a new therapy. An honest understanding of Medical Affairs situations and needs will be essential to ensure data-driven decision-making.

Medical 52
article thumbnail

Mastering the Art of Presentation: Choosing the Perfect Sample Bag for Pharma Sales Success

Contrarian Sales Techniques

In the bustling world of pharmaceutical sales, the role of a sample bag is often understated yet crucial. Options like lockable compartments and tamper-evident seals offer peace of mind and protect the contents from potential theft or tampering. The sample bag they carry isn’t just a container.

Sales 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Don’t Wait—Uncover the Clinical Endpoints that Will Matter to Payers and HCPs

PM360

The key is to demonstrate long-term outcomes, providing real-world evidence (RWE) that supports payers with early visibility into the total health system costs related to a particular disease. This option grows more critical as new therapies become available with price tags as high as $3.5

article thumbnail

Device Rep To West Sales Manager – The 2 Year Sprint With Jacob Mclaughlin Part 2

Evolve Your Success

We’re having real-life conversations. Being able to have those real-life talks with my clients also fills my cup. It’s the world. You can make something that when you fall asleep, you get paid for when you wake up because the world never sleeps. It’s the world. I still personal train on the side.

article thumbnail

Dedi Gilad

Cadensee

Unfortunately, it's a pandemic, but I think that your value proposition became very evident once COVID hit. It's already tagged by clinicians with the diagnosis, so you have to do the machine learning and the engineering side. TytoCare took a real hard, a very heavy lifting kind of project on our shoulders. Varda shalev.

article thumbnail

Ep. 005 – Dave Chase Podcast Transcript

Pharma Marketing Network

The way we challenge the status quo is to provide a proven blueprint for optimizing well-being through world-class benefits that are affordable, often costing 30-50 percent less and providing easy access through our ecosystem to align benefits advisors. In that market, the real Market, my view prices have been flat for 5 to 10 years.